Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer

NCT02278185 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma of the Prostate
Recurrent Prostate Cancer
Stage III Prostate Cancer
Stage IV Prostate Cancer

Interventions

DRUG: Enzalutamide
DRUG: leuprolide acetate
DRUG: goserelin acetate
DRUG: histrelin acetate
DRUG: triptorelin
DRUG: degarelix

Sponsor

University of Colorado, Denver